Parallel Advisors’s Astrana Health ASTH Stock Holding History

Parallel Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.62K	Buy	+107	New	+$2.53K	﹤0.01%	3281
2025 Q4	–	Sell	-41	Closed	-$1.16K	–	3774
2025 Q3	$1.16K	Buy	41 +14	+52%	+$379	﹤0.01%	3186
2025 Q2	$672	Buy	+27	New	+$760	﹤0.01%	3266
2025 Q1	–	Sell	-70	Closed	-$2.21K	–	3699
2024 Q4	$2.21K	Buy	70 +46	+192%	+$2.19K	﹤0.01%	2937
2024 Q3	$1.39K	Hold	24	–	–	﹤0.01%	2968
2024 Q2	$973	Buy	+24	New	+$952	﹤0.01%	2966
2023 Q1	–	Hold	0	–	–	–	3544
2022 Q4	–	Hold	0	–	–	–	3562
2021 Q4	–	Sell	-61	Closed	-$6K	–	3339
2021 Q3	$6K	Buy	61 +41	+205%	+$3.49K	﹤0.01%	2310
2021 Q2	$1K	Hold	20	–	–	﹤0.01%	2858
2021 Q1	$1K	Hold	20	–	–	﹤0.01%	2718
2020 Q4	$0	Buy	+20	New	+$360	﹤0.01%	2754

Other funds holding ASTH

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return